Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular Cognitive Impairment.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 17 6 2020
medline: 8 5 2021
entrez: 16 6 2020
Statut: ppublish

Résumé

Patients with coronary artery disease have an increased risk for developing vascular cognitive impairment. Endothelial function is often diminished and has been associated with lower cognitive performance in these patients. The link between endothelial function and cognition in coronary artery disease is not fully understood. Angiogenesis may play a role in mediating the association between endothelial function and cognition since angiogenic processes rely heavily on the endothelium. The aim of this study was to determine if markers of angiogenesis mediate the relationship between endothelial function and cognition in coronary artery disease patients. In 50 participants with coronary artery disease, endothelial function was assessed using peripheral arterial tonometry. Vascular endothelial growth factor (pro-angiogenic) and endostatin (anti-angiogenic) were measured in peripheral serum samples. Cognition was assessed using the Montreal Cognitive Assessment. A mediation analysis, using a bias corrected inferential bootstrapping method with 10,000 permutations, was used to determine if vascular endothelial growth factor or endostatin mediated an association between peripheral arterial tonometry measures and cognitive performance on the Montreal Cognitive Assessment. Endostatin, but not vascular endothelial growth factor, mediated a relationship between endothelial function and cognitive performance when controlling for total years of education, body mass index, coronary artery bypass graft, stent, diabetes, and diuretic use. This analysis was also significant when delayed recall was substituted for the overall score on the Montreal Cognitive Assessment. These results suggest that endostatin mediates an association between endothelial function and cognitive performance in coronary artery disease.

Sections du résumé

BACKGROUND
Patients with coronary artery disease have an increased risk for developing vascular cognitive impairment. Endothelial function is often diminished and has been associated with lower cognitive performance in these patients. The link between endothelial function and cognition in coronary artery disease is not fully understood. Angiogenesis may play a role in mediating the association between endothelial function and cognition since angiogenic processes rely heavily on the endothelium.
OBJECTIVE
The aim of this study was to determine if markers of angiogenesis mediate the relationship between endothelial function and cognition in coronary artery disease patients.
METHODS
In 50 participants with coronary artery disease, endothelial function was assessed using peripheral arterial tonometry. Vascular endothelial growth factor (pro-angiogenic) and endostatin (anti-angiogenic) were measured in peripheral serum samples. Cognition was assessed using the Montreal Cognitive Assessment. A mediation analysis, using a bias corrected inferential bootstrapping method with 10,000 permutations, was used to determine if vascular endothelial growth factor or endostatin mediated an association between peripheral arterial tonometry measures and cognitive performance on the Montreal Cognitive Assessment.
RESULTS
Endostatin, but not vascular endothelial growth factor, mediated a relationship between endothelial function and cognitive performance when controlling for total years of education, body mass index, coronary artery bypass graft, stent, diabetes, and diuretic use. This analysis was also significant when delayed recall was substituted for the overall score on the Montreal Cognitive Assessment.
CONCLUSION
These results suggest that endostatin mediates an association between endothelial function and cognitive performance in coronary artery disease.

Identifiants

pubmed: 32538839
pii: JAD200058
doi: 10.3233/JAD-200058
pmc: PMC7458520
doi:

Substances chimiques

Biomarkers 0
Endostatins 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-611

Subventions

Organisme : CIHR
ID : LANCTOTMOP-114913
Pays : Canada

Références

Neurosci Lett. 2013 Aug 29;550:60-3
pubmed: 23827227
J Alzheimers Dis. 2018;64(4):1235-1246
pubmed: 30010121
J Neurosci. 2002 Dec 15;22(24):10621-6
pubmed: 12486154
Int J Geriatr Psychiatry. 2018 Feb;33(2):279-287
pubmed: 28474775
Microvasc Res. 2009 Jun;78(1):45-50
pubmed: 19345232
BMC Geriatr. 2013 Dec 12;13:135
pubmed: 24330446
Int Heart J. 2018 Sep 26;59(5):1034-1040
pubmed: 30158387
J Alzheimers Dis. 2017;60(3):829-841
pubmed: 28598843
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1856-61
pubmed: 16766649
Stroke. 2011 Sep;42(9):2672-713
pubmed: 21778438
Neurosci Bull. 2007 Jan;23(1):35-40
pubmed: 17592523
Behav Res Ther. 2017 Nov;98:39-57
pubmed: 27865431
Cardiovasc Psychiatry Neurol. 2012;2012:367516
pubmed: 23243502
J Am Geriatr Soc. 2010 Aug;58(8):1519-25
pubmed: 20646102
Psychol Sci. 2007 Mar;18(3):233-9
pubmed: 17444920
Anesth Analg. 2007 May;104(5):1023-8, tables of contents
pubmed: 17456647
J Stud Alcohol Drugs. 2018 Mar;79(2):171-181
pubmed: 29553343
Int J Cardiol. 2017 Mar 1;230:80-84
pubmed: 28038797
Am J Med. 1984 May 31;76(5B):86-90
pubmed: 6328990
Parkinsonism Relat Disord. 2017 May;38:31-34
pubmed: 28215728
Neurology. 2013 Sep 10;81(11):984-91
pubmed: 23935179
J Am Geriatr Soc. 2007 Oct;55(10):1613-7
pubmed: 17711428
Exp Physiol. 2010 Sep;95(9):955-70
pubmed: 20562294
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):268-74
pubmed: 15031312
Biomark Med. 2017 Oct;11(10):905-916
pubmed: 28976780
Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):206-18
pubmed: 24632990
J Biol Chem. 2011 Oct 28;286(43):37158-67
pubmed: 21896479
Heart. 2003 Dec;89(12):1411-5
pubmed: 14617549
Am J Pathol. 2001 Jul;159(1):313-20
pubmed: 11438478
Ann Thorac Surg. 2003 May;75(5):1377-84; discussion 1384-6
pubmed: 12735550
Dis Markers. 2014;2014:135357
pubmed: 25110384
N Engl J Med. 2001 Feb 8;344(6):395-402
pubmed: 11172175
Stroke. 2006 Sep;37(9):2220-41
pubmed: 16917086
PLoS One. 2017 Sep 8;12(9):e0184244
pubmed: 28886155
Am J Cardiol. 2007 Feb 15;99(4):494-8
pubmed: 17293192
Expert Rev Mol Med. 2019 Dec 04;21:e7
pubmed: 31796147
Biochimie. 2016 Mar;122:314-23
pubmed: 26458976
Stroke. 2007 Feb;38(2):308-12
pubmed: 17204686
Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H1-H20
pubmed: 27793855
J Alzheimers Dis. 2017;59(3):893-901
pubmed: 28697562
Am J Geriatr Psychiatry. 2015 Jul;23(7):754-63
pubmed: 25499674
Diab Vasc Dis Res. 2016 Jan;13(1):49-55
pubmed: 26408643
Circulation. 2003 Jun 10;107(22):2805-9
pubmed: 12771004
J Mol Neurosci. 2015 Jun;56(2):363-70
pubmed: 25859933
Heart. 2005 Mar;91(3):365-6
pubmed: 15710722
Behav Brain Res. 2014 May 15;265:171-80
pubmed: 24589546
J Am Coll Cardiol. 2004 Dec 7;44(11):2137-41
pubmed: 15582310
Behav Brain Res. 2012 Dec 1;235(2):210-7
pubmed: 22889927
Nat Rev Cardiol. 2018 Sep;15(9):555-565
pubmed: 29795441
Arq Bras Cardiol. 2017 Nov;109(5):448-456
pubmed: 28977054
JAMA Neurol. 2019 Jan 1;76(1):116-117
pubmed: 30535279
Am Heart J. 2003 Jul;146(1):168-74
pubmed: 12851627
Scand Cardiovasc J. 2018 Dec;52(6):315-319
pubmed: 30474426
Physiol Res. 2010;59(3):385-92
pubmed: 19681661
J Alzheimers Dis. 2017;58(3):885-896
pubmed: 28505971
Hypertension. 2013 Dec;62(6):1146-51
pubmed: 24082055
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):291-308
pubmed: 25780786
J Am Heart Assoc. 2018 Mar 26;7(7):
pubmed: 29581224
Front Aging Neurosci. 2017 Aug 02;9:255
pubmed: 28824417
Neuroimage. 2008 Sep 1;42(3):1237-43
pubmed: 18585467
Neuroimage. 2013 Jan 15;65:416-23
pubmed: 23032491
Neurobiol Aging. 2007 Mar;28(3):477-83
pubmed: 16469418
Coron Artery Dis. 2014 Aug;25(5):421-6
pubmed: 24584030
Nat Rev Cardiol. 2014 May;11(5):276-89
pubmed: 24663092
Psychol Methods. 2018 Jun;23(2):191-207
pubmed: 29283590
Atherosclerosis. 2019 May;284:202-208
pubmed: 30959314
Psychosom Med. 2019 Feb/Mar;81(2):184-191
pubmed: 30383709
Alzheimers Dement. 2015 Jun;11(6):710-7
pubmed: 25510382

Auteurs

Cameron Isaacs-Trepanier (C)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.

Mahwesh Saleem (M)

Department of Psychiatry, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Nathan Herrmann (N)

Department of Psychiatry, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Walter Swardfager (W)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Paul I Oh (PI)

KITE, UHN-Toronto Rehab, Toronto, Ontario, Canada.

Benjamin I Goldstein (BI)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
Department of Psychiatry, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Jane Mitchell (J)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.

Kim S Sugamori (KS)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.

Krista L Lanctôt (KL)

Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
Department of Psychiatry, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
KITE, UHN-Toronto Rehab, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH